The effect of triphala lavender tablets on the treatment of children with attention deficit/hyperactivity disorder

Abstract

Background: Attention deficit/hyperactivity disorder (ADHD) is a common psychiatric disorder in the children. The purpose of this study was to evaluate the efficacy of Triphala Lavender tablets as an adjuvant therapy along with methylphenidate on the treatment of children with attention deficit/hyperactivity disorder. Methods: In this clinical trial study that was done in Isfahan Province, Iran, in 2016, 44 children with attention deficit/hyperactivity disorder were enrolled according to inclusion (aged between 6 to 12 years) and exclusion (failure to follow up) criteria. The patients were randomly divided into two group as intervention (treated with methylphenidate and Triphala lavender tablets) and placebo (treated with methylphenidate and placebo). Patients were treated for 8 weeks. The assessment tool was Attention Deficit/Hyperactivity Disorder Rating Scale-IV (ADHD-RS-IV), which was used at the onset, and 2, 4, and 8 weeks after the intervention. Findings: The ADHD-RS-IV scores significantly decreased in both groups after intervention (P < 0.001 for both). In addition, the ADHD-RS-IV in the intervention group was significantly lower than placebo group at the 4th week after the intervention (P = 0.042); but there was no significant difference between the two groups in ADHD-RS-IV at onset, and 2 and 8 weeks after the intervention (P > 0.050 for all). Conclusion: The use of Triphala Lavender tablets as an adjuvant therapy may be effective in patients with attention deficit/hyperactivity disorder, but due to limited study about the role of Triphala Lavender tablets in treatment of these patients, we need future studies with larger sample sizes and longer time. © 2018, Isfahan University of Medical Sciences(IUMS). All rights reserved